Journal
/
免疫与感染
/
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
JoVE 杂志
免疫与感染
This content is Free Access.
JoVE 杂志 免疫与感染
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

11,019 Views

•

12:43 min

•

January 06, 2014

DOI:

10.3791/50561-v

DOI:
10.3791/50561-v

•

12:43 min
January 06, 2014

•

3 Views
, , , , , , , , ,
1Department of Surgery,University of Michigan, 2Department of Internal Medicine,University of Michigan, 3Department of Otolaryngology,University of Michigan

Summary

Automatically generated

Evaluated in syngeneic immunocompetent hosts, cancer stem cell (CSC) based dendritic cell (DC) vaccine demonstrated significantly higher antitumor immunity than traditional DC vaccines pulsed with heterogeneous bulk tumor cells.

Explore More Videos

Cancer Stem CellsDendritic Cell VaccineMelanomaSquamous CancerALDHAntitumor ImmunityIFN-γGM-CSF

Read Article

Cite this Article

Li, Q., Lu, L., Tao, H., Xue, C., Teitz-Tennenbaum, S., Owen, J. H., Moyer, J. S., Prince, M. E., Chang, A. E., Wicha, M. S. Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells. J. Vis. Exp. (83), e50561, doi:10.3791/50561 (2014).

Download .ris file

Copy

Share Video

.

Copy